HA
CDMO

Harborview Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Harborview Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,124
Closed -$64K – 91
2019
Q3 		$64K Hold
12,124
– – 0.05% 85
2019
Q2 		$68K Hold
12,124
– – 0.06% 83
2019
Q1 		$52K Buy
+12,124
New +$49.5K 0.05% 80
2018
Q4 		– Sell
-12,339
Closed -$85K – 64
2018
Q3 		$85K Buy
12,339
+215
+2% +$1.27K 0.09% 63
2018
Q2 		$48K Buy
+12,124
New +$42.1K 0.04% 74

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harborview Advisors's CDMO Position: Q4 2019 in Review

Harborview Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2019, closing a stake of 12,124 shares — an estimated $64K sold.

Harborview Advisors first reported a position in CDMO in Q2 2018 and held it in 5 quarters. The position peaked at $85K in Q3 2018. 114 funds tracked by Wall St. Rank hold CDMO as of Q4 2019.

  • Harborview Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Harborview Advisors sold 12,124 Avid Bioservices, Inc. Common Stock shares in Q4 2019, an estimated $64K.
  • Harborview Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • Harborview Advisors's Avid Bioservices, Inc. Common Stock position peaked at $85K in Q3 2018.
  • 114 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2019.

Based on Harborview Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.